| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| United States (Primary) | PRIMARYUSA | Univ | 6,179 | 73,614,390 | 0.06% | 0.72% | 2.20% | 5.77% | 17.01% | 13.02% |
| Healthcare | HEALTHCARE | Sector | 1,168 | 6,985,044 | 1.17% | 4.61% | 7.39% | 13.57% | 19.27% | 7.19% |
| Biopharmaceuticals | BIOPHARMA | SubSec | 600 | 3,574,436 | 1.42% | 6.50% | 10.81% | 20.53% | 30.54% | 19.30% |
| System-Specific Biopharmaceuticals | BIOPHARMASYS | Industry | 285 | 1,564,176 | 1.95% | 7.76% | 18.03% | 34.08% | 35.80% | 22.87% |
| Digestive System Biopharmaceuticals | DIGESTIVE | SubInd | 28 | 31,757 | -1.03% | 4.73% | 9.97% | 31.79% | 73.94% | 26.85% |
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| Ironwood Pharmaceuticals, Inc. | IRWD:USAIRWD:USA | Stock | 1 | 506 | 7.61% | 50.97% | 110.14% | 201.94% | 423.22% | -34.94% |
| Madrigal Pharmaceuticals, Inc. | MDGL:USAMDGL:USA | Stock | 1 | 12,009 | -2.32% | 11.15% | 21.01% | 43.02% | 81.26% | 55.73% |
| Phathom Pharmaceuticals, Inc. | PHAT:USAPHAT:USA | Stock | 1 | 1,039 | 1.81% | 10.09% | 16.96% | 42.77% | 320.11% | 11.60% |
| Arrowhead Pharmaceuticals, Inc. | ARWR:USAARWR:USA | Stock | 1 | 5,722 | -0.19% | 2.75% | 15.18% | 101.95% | 170.01% | 88.53% |
| Spyre Therapeutics, Inc. | SYRE:USASYRE:USA | Stock | 1 | 1,425 | 0.34% | 2.54% | 11.57% | 38.23% | 61.14% | -40.46% |
| Digestive System Biopharmaceuticals | DIGESTIVE | SubInd | 28 | 31,757 | -1.03% | 4.73% | 9.97% | 31.79% | 73.94% | 26.85% |
| S&P 500 | SPY:USASPY:USA | Benchmark | 14,204 | 97,233,754 | 0.06% | 0.86% | 3.19% | 6.50% | 16.40% | 15.52% |
| Akero Therapeutics, Inc. | AKRO:USAAKRO:USA | Stock | 1 | 4,352 | 0.09% | 0.46% | 0.91% | 9.96% | 35.89% | 64.35% |
| Mirum Pharmaceuticals, Inc. | MIRM:USAMIRM:USA | Stock | 1 | 3,632 | -0.76% | 0.98% | -3.41% | 4.20% | 56.32% | 70.10% |
| Wave Life Sciences Ltd. | WVE:USAWVE:USA | Stock | 1 | 1,115 | -4.20% | -13.50% | -11.85% | -28.74% | 10.40% | -57.69% |
| Monopar Therapeutics, Inc. | MNPR:USAMNPR:USA | Stock | 1 | 506 | -1.02% | 0.10% | -13.34% | 131.25% | 108.80% | 395.68% |
* Colors indicate performance relative to the benchmark.